Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 2/20 | 0.91 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.91 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.80 |
| ▸ | DRD1 | P21728 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31237191 | 1.00 | HSPD1 (0.91) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL3465034 | 1.00 | HSPD1 (0.91) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL19708888 | 1.00 | HSPD1 (0.91) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| Eprinomectin SCHEMBL120548 | 0.97 | HSPD1 (0.98) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| Eprinomectin SCHEMBL29392105 | 0.97 | HSPD1 (0.98) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL248270 | 0.96 | HSPD1 (1.00) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL248559 | 0.96 | HSPD1 (1.00) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL29355814 | 0.96 | HSPD1 (1.00) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL19708763 | 0.96 | HSPD1 (1.00) | HSPD1HSPE1ADORA3DRD1MEN1 | |
| SCHEMBL29523079 | 0.96 | HSPD1 (1.00) | HSPD1HSPE1ADORA3DRD1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11985976-B2 | Mixture of mectins and pyrethroids and uses thereof | VALENT BIOSCIENCES LLC (US) | 2024-05-21 | — | — | US | disclosed |
| US-20210386065-A1 | MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF | VALENT BIOSCIENCES LLC | 2021-12-16 | — | — | US | disclosed |
| EP-3220888-B1 | EPRINOMECTIN PARENTERAL COMPOSITIONS | CEVA SANTE ANIMALE (FR) | 2021-10-27 | — | — | EP | disclosed |
| US-20170355724-A1 | ANTHELMINTHIC MACROLIDE SYNTHESIS | NORBROOK LABORATORIES LIMITED (GB) | 2017-12-14 | — | — | US | disclosed |
| EP-3023092-A1 | Eprinomectin parenteral compositions | Ceva Sante Animale (FR) | 2016-05-25 | — | — | EP | disclosed |
| US-9320752-B2 | Pesticidal ear tag | Y-TEX CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| US-20130273134-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION | 2013-10-17 | — | — | US | disclosed |
| US-8425925-B2 | Pesticidal tag | Y-TEX CORPORATION (US) | 2013-04-23 | — | — | US | disclosed |
| US-20090111759-A1 | Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof | CHEMINOVA A/S (DK) | 2009-04-30 | — | — | US | disclosed |
| EP-2033518-A1 | Pesticidal compositions | Cheminova A/S (DK) | 2009-03-11 | — | — | EP | disclosed |
| US-20090004236-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION | 2009-01-01 | — | — | US | disclosed |
| EP-1849363-A1 | Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin | Cheminova A/S (DK) | 2007-10-31 | — | — | EP | disclosed |
| US-20050118222-A1 | Product to combat ticks and the process for the product's preparation | WOLFF BRUCE ZBIG A (BR) | 2005-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111759-A1 | Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof | SLC6A1, GABRE, GRIN1 | HSPD1 1859/4885HSPE1 951/4885ADORA3 439/4885 |
| US-20210386065-A1 | MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF | ACHE, DDT, PTMS | HSPD1 1466/4885HSPE1 1503/4885ADORA3 2478/4885 |
| US-11985976-B2 | Mixture of mectins and pyrethroids and uses thereof | ACHE, DDT, PTMS | HSPD1 1466/4885HSPE1 1503/4885ADORA3 2478/4885 |
| US-20130273134-A1 | PESTICIDAL EAR TAG | ABAT, AADAC, BRDT | HSPD1 441/4885HSPE1 266/4885ADORA3 1615/4885 |
| US-20090004236-A1 | PESTICIDAL EAR TAG | TMPO, BRDT, AADAC | HSPD1 1318/4885HSPE1 709/4885ADORA3 2647/4885 |
| US-20170355724-A1 | ANTHELMINTHIC MACROLIDE SYNTHESIS | ABAT, EEF1A2, EEF2 | HSPD1 1170/4885HSPE1 2174/4885ADORA3 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.